Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Drug Res (Stuttg) ; 66(6): 306-11, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26979753

ABSTRACT

An antimuscarinic therapy may increase the risk of voiding dysfunction. However, it is unclear whether the relative risk of voiding dysfunction is different among antimuscarinics. Therefore we determined the potencies both in enhancing the bladder capacity (BC), effectiveness, and in decreasing the maximum urinary flow rate (Qmax), voiding dysfunction, to compare their therapeutic indices.Under urethane anesthesia, urinary flow rate was measured at distal urethra using an ultrasonic flow meter in female Sprague-Dawley rats with functional urethral obstruction induced by a continuous i. v. infusion of α1-adrenoceptor agonist A-61603 (0.03 µg/kg/min). In a separate group of urethane-anesthetized rats without urethral obstruction, an intermittent cystometry was performed to determine BC.Intravenous imidafenacin and oxybutynin produced a significant dose-dependent decrease in Qmax with the minimum doses of 0.03 and 1 mg/kg, respectively. Imidafenacin and oxybutynin markedly increased BC, with minimum doses of 0.01 and 3 mg/kg, respectively. At the minimum dose to increase BC, oxybutynin caused a significant increase in residual urine volume with a significant decrease in voiding efficiency, whereas imidafenacin had no influence on these values. The relative influence index, which is the ratio of the minimum influence dose between in decreasing of Qmax and in increasing of BC, of imidafenacin was 10 fold higher than that of oxybutynin.This study suggests that imidafenacin has a lower relative risk of voiding difficulty compared with oxybutynin in rats. These results provide new information that antimuscarinics may have varying degrees of impact on voiding difficulty.


Subject(s)
Imidazoles/adverse effects , Mandelic Acids/adverse effects , Muscarinic Antagonists/adverse effects , Urinary Bladder/drug effects , Urination Disorders/physiopathology , Animals , Female , Rats , Urethral Obstruction/chemically induced , Urethral Obstruction/physiopathology , Urinary Bladder/physiology , Urination Disorders/chemically induced
3.
Rev. esp. investig. quir ; 18(1): 32-34, 2015. ilus
Article in Spanish | IBECS | ID: ibc-137255

ABSTRACT

Introducción: la incidencia del divertículo uretral es menor en hombres, siendo más frecuentes los casos adquiridos. Es extraordinario encontrar una litiasis ocupando la totalidad del divertículo. Caso clínico: presentamos varón de 34 años con litiasis en divertículo uretral secundaria a intervención quirúrgica previa. Conclusión: mujeres el tratamiento de elección será la diverticulectomía con la técnica más simple posible


Introduction: the urethral diverticulum incidence is lower in men than in women. Acquired cases are more frequent. Is extremely rare to find a diverticulum lithiasis. Case report: we present a 34 years old male with urethral diverticulum lithiasis due to previous urethral surgery. Conclusion: treatment of choice is diverticulectomy with lithiasis removement


Subject(s)
Humans , Male , Cholelithiasis/metabolism , Cholelithiasis/pathology , Diverticulum/congenital , Diverticulum/diagnosis , Urethral Obstruction/chemically induced , Urethral Obstruction/complications , Medical History Taking/methods , Pharmaceutical Preparations/administration & dosage , Cholelithiasis/complications , Cholelithiasis/surgery , Diverticulum/metabolism , Diverticulum/pathology , Urethral Obstruction/metabolism , Urethral Obstruction/pathology , Medical History Taking/standards , Pharmaceutical Preparations/supply & distribution
4.
J Matern Fetal Neonatal Med ; 24(2): 305-12, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20504076

ABSTRACT

OBJECTIVE: The teratogenic potential of some antithyroid drugs is known, but the aim of the study was to estimate the risk of congenital abnormalities (CAs) in the offspring of pregnant women with hyperthyroidism with or without antithyroid drug treatment. METHOD: Comparison of the occurrence of medically recorded hyperthyroidism who had malformed fetuses/newborns (cases) and who delivered healthy babies (controls) in the population-based Hungarian Case-Control Surveillance System of CAs, 1980-1996. Of 22,843 cases with congenital abnormalities, 71 (0.31%) while of 38,151 controls, 116 (0.30%) had mothers with hyperthyroidism. The rate of hyperthyroidism in the mothers of cases with different CAs and in the mothers of matched controls was compared. RESULTS: Preeclampsia-eclampsia occurred more frequently in pregnant women with hyperthyroidism without antithyroid treatment. The analysis of specific groups of CAs showed an association between hyperthyroidism in pregnant women and obstructive defects of urinary tract in their children. CONCLUSIONS: The lack of appropriate treatment of pregnant women affected with hyperthyroidism seems to be the major problem, because it would be necessary to prevent the hyperthyroidism related risks of pregnancy complications and CAs which exceed the risk of antithyroid medication in these pregnant women.


Subject(s)
Hyperthyroidism/epidemiology , Pregnancy Complications/epidemiology , Urethral Obstruction/epidemiology , Urinary Tract/abnormalities , Urologic Diseases/congenital , Urologic Diseases/epidemiology , Abnormalities, Drug-Induced/epidemiology , Abnormalities, Drug-Induced/etiology , Adult , Antithyroid Agents/adverse effects , Antithyroid Agents/therapeutic use , Case-Control Studies , Female , Humans , Hungary/epidemiology , Hyperthyroidism/complications , Hyperthyroidism/drug therapy , Infant, Newborn , Population Surveillance , Pregnancy , Pregnancy Complications/drug therapy , Pregnancy Complications/etiology , Pregnant Women , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/epidemiology , Urethral Obstruction/chemically induced , Urethral Obstruction/congenital , Young Adult
5.
Zentralbl Gynakol ; 128(2): 68-70, 2006 Apr.
Article in German | MEDLINE | ID: mdl-16673247

ABSTRACT

PURPOSE: To evaluate the cause and management of paraurethral abscess developing after injection of a mixture of hyaluronic acid and dextranomer (Zuidex) for treating stress urinary incontinence. PATIENTS AND METHOD: A total of 127 women having undergone midurethral Zuidex injection and 34 women after endoscopically guided Deflux injection into the tissue around the bladder neck were followed up 1 to 24 months after the intervention. At follow-up, the paraurethral tissue was evaluated clinically by gynecologic examination and by introital ultrasound. RESULTS: Thirteen of 127 women (10 %) having undergone midurethral Zuidex injection had a sterile paraurethral abscess that was treated by transvaginal puncture (1 to 3 punctures with removal of 10-60 ml of fluid per patient). No case of postoperative paraurethral abscess formation was demonstrated in the control group treated by Deflux injection into the area around the bladder neck. CONCLUSIONS: Paraurethral abscess must be excluded in the postinterventional follow-up of patients after Zuidex injection. Patients in whom an abscess is demonstrated can be treated by transvaginal puncture. Abscess formation can be avoided by injecting dextranomer/hyaluronic acid into the area around the bladder neck.


Subject(s)
Abscess/chemically induced , Dextrans/adverse effects , Hyaluronic Acid/analogs & derivatives , Urethra/drug effects , Urethral Diseases/chemically induced , Urinary Incontinence, Stress/therapy , Abscess/diagnosis , Adult , Cystoscopy , Dextrans/administration & dosage , Endosonography , Female , Follow-Up Studies , Gels , Humans , Hyaluronic Acid/administration & dosage , Hyaluronic Acid/adverse effects , Injections , Urethral Diseases/diagnosis , Urethral Obstruction/chemically induced , Urethral Obstruction/diagnosis , Urodynamics/drug effects
6.
Am J Med Genet A ; 136(1): 1-7, 2005 Jul 01.
Article in English | MEDLINE | ID: mdl-15937944

ABSTRACT

The purpose of this case-control study was to determine whether multivitamin use is associated with the occurrence of multiple congenital anomalies (MCA). MCA case-infants were infants with two or more major birth defects affecting at least two different organ systems, with no recognized chromosome abnormality or single gene disorder. Control-infants were a random sample of live births with no major birth defects from the same population (metropolitan Atlanta) and time period (1993-1997) as the case-infants. Exposure to multivitamins, cereals, and supplements was ascertained from a maternal telephone interview and classified based on folic acid content. We compared women who used multivitamins three or more times per week with women who were not exposed to vitamins/cereals/supplements during the periconceptional period (3 months before pregnancy through the first trimester), adjusting for maternal age, education, race/ethnicity, first degree family history of a major birth defect, pre-pregnancy maternal body mass index, gravidity, and first trimester alcohol use and cigarette smoking. Periconceptional multivitamin use was associated with MCA among all infants (adjusted odds ratio [aOR]=2.4, 95% confidence interval [CI] 0.9-6.7), and especially when analysis was limited to those with no family history of major defects (aOR=4.0, 95% CI 1.3-12.8). MCA-infants with urinary obstructive defects were more common among multivitamin-exposed infants than among unexposed infants, but this defect did not occur within a consistent pattern of defects. While these findings provide some support for one previous study, the interpretation remains unclear given the proven protective effect of multivitamins containing folic acid on isolated neural tube defects and possibly other types of defects.


Subject(s)
Abnormalities, Drug-Induced/etiology , Abnormalities, Multiple/chemically induced , Vitamins/administration & dosage , Abnormalities, Multiple/pathology , Case-Control Studies , Dietary Supplements , Female , Folic Acid/administration & dosage , Folic Acid/adverse effects , Georgia , Humans , Infant, Newborn , Maternal Age , Odds Ratio , Preconception Care , Pregnancy , Pregnancy Trimester, First , Risk Assessment/methods , Risk Assessment/statistics & numerical data , Risk Factors , Urethral Obstruction/chemically induced , Vitamins/adverse effects
7.
J Urol ; 156(6): 2098-103, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8911398

ABSTRACT

PURPOSE: Analysis of voiding pattern, urodynamic measurements and immunohistochemical methods were performed in order to evaluate the effects of neonatal estrogenization on voiding functions of adult male mice. MATERIALS AND METHODS: Metabolic cages were used for recording the voiding volumes and frequencies. Bladder pressure and mean flow during voiding were measured in transvesical cystometry. Location of estrogen receptors and organization of smooth muscles in lower urinary track were demonstrated using immunohistochemical staining. RESULTS: Neonatally estrogenized (neoDES) male mice had lower voided urine volumes (the average voided urine volume and average of the three largest volumes) and higher voiding frequencies than control mice. In transvesical cystometry, the maximum bladder pressure during the high-frequency oscillation phase of voiding was significantly elevated. The average urinary flow rate was decreased. CONCLUSIONS: Urodynamically, these findings are consistent with the concept that neonatally estrogenized mice have infravesical obstruction. The predominance of estrogen receptors in the periurethral region and changes in urethral smooth muscle cells immunocytochemically stained with alpha-actin-antibody support the concept of urethral wall musculature as a target of estrogen action.


Subject(s)
Diethylstilbestrol/administration & dosage , Estrogens, Non-Steroidal/administration & dosage , Urethral Obstruction/chemically induced , Age Factors , Animals , Animals, Newborn , Female , Male , Mice , Muscle, Smooth/pathology , Receptors, Estrogen/analysis , Urethra/chemistry , Urethra/pathology , Urinary Bladder/chemistry , Urinary Bladder/pathology , Urinary Bladder/physiopathology , Urination
9.
Postgrad Med J ; 65(762): 260-1, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2480586

ABSTRACT

Three cases are described in which bladder outflow obstruction was produced by ipratropium bromide, a widely used anticholinergic bronchodilator which has been regarded as virtually free from systemic side effects. Many patients treated with ipratropium bromide are elderly males in whom prostatic hypertrophy is common and in these circumstances, large doses should be used with caution.


Subject(s)
Atropine Derivatives/adverse effects , Ipratropium/adverse effects , Urethral Obstruction/etiology , Aged , Drug Administration Schedule , Humans , Ipratropium/administration & dosage , Male , Prostatic Hyperplasia/complications , Urethral Obstruction/chemically induced
10.
Am J Vet Res ; 46(2): 391-400, 1985 Feb.
Article in English | MEDLINE | ID: mdl-3994104

ABSTRACT

Aggregates of struvite crystals caused urethral obstruction in a high percentage of cats fed moist and dry diets supplemented with Mg oxide. Some of the diets were associated with cystolith formation as well. The percentage of Mg in the experimental diets was a misleading indicator of Mg intake because of differences between moist and dry diets in their caloric density. Magnesium homeostasis was maintained in cats ingesting large quantities of Mg. Tissue (kidney, muscle, and rib) concentrations of Mg were the same in cats fed high Mg and control diets. Plasma Mg concentration was increased only in cats ingesting the largest amount of Mg. Magnesium homeostasis was maintained by a marked increase in urine Mg excretion. However, urine Mg concentration was not directly related to Mg intake, apparently because of differences between diets in intestinal absorption of Mg. Urethral obstruction of experimental cats was not associated with a transient increase in Mg intake, nor did obstructing cats have higher urine Mg concentrations than did nonobstructing cats fed the same diet. This observation indicates that factor(s) other than urine Mg concentration are important in urethral obstruction. Cats with urethral obstruction due to naturally occurring disease, feline urological syndrome (FUS), had markedly lower urine Mg concentrations than cats fed high Mg diets. This finding refutes the theory that cats develop FUS because of primary Mg hyperabsorptive phenomena or because of a primary urinary leak of Mg. It also indicates that factors other than urine Mg concentration are involved in the genesis of naturally occurring urethral obstruction. Another difference between the natural and the induced disease was related to the character of the urinary precipitates. Experimental diets higher in Mg concentration caused urolith formation, which is uncommon with FUS. Lower Mg diets caused obstruction with aggregates of crystals, but mucus was not observed. However, in the experimental disease induced in the present study, urinary precipitates were predominantly or exclusively struvite, as has been reported in the natural disease. Many similarities were seen between the diet-induced disease and FUS, but factors in addition to Mg intake are involved in the natural disease. The importance of Mg, compared with the undefined factors, remains to be established.


Subject(s)
Cat Diseases/chemically induced , Hematuria/veterinary , Magnesium Compounds , Magnesium Oxide/adverse effects , Urethral Obstruction/veterinary , Urination Disorders/veterinary , Animals , Cat Diseases/metabolism , Cats , Food, Fortified , Hematuria/chemically induced , Hematuria/metabolism , Magnesium , Male , Minerals/blood , Minerals/urine , Phosphates , Struvite , Syndrome/veterinary , Urethral Obstruction/chemically induced , Urethral Obstruction/metabolism , Urination Disorders/chemically induced , Urination Disorders/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...